Justin Taylor Shares an Article on Relapsed-Refractory Chronic Lymphocytic Leukemia
Justin Taylor/X

Justin Taylor Shares an Article on Relapsed-Refractory Chronic Lymphocytic Leukemia

Justin Taylor, Associate Professor, Sylvester Comprehensive Cancer Center, shared a post on X:

“An indirect comparison of pirtobrutinib with second-generation covalent Bruton tyrosine kinase inhibitors in BTKi naive, and relapsed-refractory chronic lymphocytic leukemia: results of a network meta-analysis: Leukemia and Lymphoma: Vol 0, No 0 – Get Access.”

Title: An indirect comparison of pirtobrutinib with second-generation covalent Bruton tyrosine kinase inhibitors in BTKi naive, and relapsed-refractory chronic lymphocytic leukemia: results of a network meta-analysis

Authors: Stefano Molica, Diana Giannarelli, David Allsup

Read the Article

Justin Taylor

Other articles featuring Justin Taylor on OncoDaily.